148 results
8-K
EX-99.2
CDXC
Chromadex Corp
6 Mar 24
ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2023 Results
4:02pm
disciplined cash management and optimization measures throughout 2023, while continuing to invest in key areas to support both immediate and long term growth
8-K
EX-99.1
CDXC
Chromadex Corp
6 Mar 24
ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2023 Results
4:02pm
improvements and equipment, net
Intangible assets, net
Right-of-use assets
Other long-term assets
Total assets
Liabilities and Stockholders' Equity
Current
8-K
EX-99.1
geur70 lo
8 Nov 23
ChromaDex Corporation Reports Third Quarter 2023 Financial Results
4:02pm
8-K
EX-99.2
rnd vxs7zq
8 Nov 23
ChromaDex Corporation Reports Third Quarter 2023 Financial Results
4:02pm
8-K
EX-99.1
pxedyl3
9 Aug 23
ChromaDex Corporation Reports Second Quarter 2023 Financial Results
4:02pm
8-K
EX-99.2
ziui6gpd0praqo6a
10 May 23
ChromaDex Corporation Reports First Quarter 2023 Financial Results
4:02pm
8-K
EX-99.1
y3z5n0r3br
10 May 23
ChromaDex Corporation Reports First Quarter 2023 Financial Results
4:02pm
8-K
EX-99.2
0t7jbj
2 Nov 22
ChromaDex Corporation Reports Third Quarter 2022 Financial Results
4:02pm
8-K
EX-99.1
xrklf
2 Nov 22
ChromaDex Corporation Reports Third Quarter 2022 Financial Results
4:02pm
8-K
EX-99.1
h3tcz7czvod5w
11 Oct 22
ChromaDex and Nestlé Health Science Announce New Niagen® Commercial Supply Agreement and $5 Million Investment
4:05pm